Andon Health Co., Ltd.

SZSE:002432 Stock Report

Market Cap: CN¥19.3b

Andon Health Past Earnings Performance

Past criteria checks 1/6

Andon Health has been growing earnings at an average annual rate of 60.3%, while the Medical Equipment industry saw earnings growing at 8.9% annually. Revenues have been growing at an average rate of 54.8% per year. Andon Health's return on equity is 1.4%, and it has net margins of 19.6%.

Key information

60.3%

Earnings growth rate

60.3%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate54.8%
Return on equity1.4%
Net Margin19.6%
Last Earnings Update30 Sep 2023

Recent past performance updates

Recent updates

Andon Health Co., Ltd. (SZSE:002432) Stock Rockets 28% But Many Are Still Ignoring The Company

Mar 22
Andon Health Co., Ltd. (SZSE:002432) Stock Rockets 28% But Many Are Still Ignoring The Company

Andon Health's (SZSE:002432) Returns On Capital Are Heading Higher

Mar 19
Andon Health's (SZSE:002432) Returns On Capital Are Heading Higher

A Look At The Fair Value Of Andon Health Co., Ltd. (SZSE:002432)

Mar 01
A Look At The Fair Value Of Andon Health Co., Ltd. (SZSE:002432)

Revenue & Expenses Breakdown
Beta

How Andon Health makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:002432 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 234,4718771,420307
30 Jun 235,3321,5721,459308
31 Mar 236,0742,3201,368277
31 Dec 2226,31516,0302,017265
30 Sep 2226,19616,9091,573138
30 Jun 2225,09516,0971,384112
31 Mar 2223,81215,1821,38287
01 Jan 222,39790952067
30 Sep 211,191-7144677
30 Jun 211,5373955075
31 Mar 212,02923462389
31 Dec 202,00824260277
30 Sep 201,801509487122
30 Jun 201,424374382100
31 Mar 2085614829291
31 Dec 197066628680
30 Sep 19668-626553
30 Jun 19620924660
31 Mar 19594322463
31 Dec 185641321669
30 Sep 18531-139148162
30 Jun 18538-164191139
31 Mar 18582-175232116
31 Dec 17598-16625894
30 Sep 17556263260
30 Jun 17566103140
31 Mar 17445132880
31 Dec 16420142670
30 Sep 16431-1832770
30 Jun 16384-1542500
31 Mar 16403-1482410
31 Dec 15398-1512350
30 Sep 15368-272150
30 Jun 15391-222210
31 Mar 15430-72200
31 Dec 14425102120
30 Sep 14433-451810
30 Jun 14429-231600
31 Mar 14431-101560
31 Dec 13408-91520
30 Sep 1345341540
30 Jun 1339761380

Quality Earnings: 002432 has a large one-off loss of CN¥586.7M impacting its last 12 months of financial results to 30th September, 2023.

Growing Profit Margin: 002432's current net profit margins (19.6%) are lower than last year (64.5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 002432 has become profitable over the past 5 years, growing earnings by 60.3% per year.

Accelerating Growth: 002432's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 002432 had negative earnings growth (-94.8%) over the past year, making it difficult to compare to the Medical Equipment industry average (-1.4%).


Return on Equity

High ROE: 002432's Return on Equity (1.4%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.